Skip to main content
Top
Published in: Cancer Causes & Control 11/2019

01-11-2019 | Breast Cancer | Original Paper

Do breast quadrants explain racial disparities in breast cancer outcomes?

Authors: Yunan Han, Justin Xavier Moore, Marvin Langston, Lindsay Fuzzell, Saira Khan, Marquita W. Lewis, Graham A. Colditz, Ying Liu

Published in: Cancer Causes & Control | Issue 11/2019

Login to get access

Abstract

Purpose

Tumors of the inner quadrants of the breast are associated with poorer survival than those of the upper-outer quadrant. It is unknown whether racial differences in breast cancer outcomes are modified by breast quadrant, in addition to comparisons among Asian subgroups.

Methods

Using the Surveillance, Epidemiology, and End Results database, we analyzed data among women diagnosed with non-metastatic invasive breast cancer between 1990 and 2014. We performed Cox proportional hazards regression models to assess the associations of race with breast cancer-specific survival and overall survival, stratified by breast quadrants. The models were adjusted for age, year of the diagnosis, tumor size, grade, histological type, tumor laterality, lymph node, estrogen receptor, progesterone receptor, and treatments.

Results

Among 454,154 patients (73.0% White, 10.0% Black, 7.8% Asian/PI, and 9.2% Hispanic), 54.3% had tumors diagnosed in the upper-outer quadrant of the breast. Asian/PI women were more likely than White to have tumors diagnosed in the nipple/central portion of the breast and were less likely to have diagnosed in the upper-outer quadrant (P < 0.001), despite a similar distribution of breast quadrant between Black, Hispanic, and White women. Compared with White women, the multivariable-adjusted hazard ratios of breast cancer-specific mortality were 1.41 (95% CI 1.37–1.44) in Black women, 0.82 (95% CI 0.79–0.85) in Asian women, and 1.05 (95% CI 1.02–1.09) in Hispanic women. Among Asian subgroups, Japanese American women had a lower risk of breast cancer-specific mortality (HR = 0.68, 95% CI 0.62–0.74) compared with White women. Overall survival was similar to breast cancer-specific survival in each race group. The race-associated risks did not vary significantly by breast quadrants for breast cancer-specific mortality and all-cause mortality.

Conclusions

Differences in breast cancer survival by race could not be attributed to tumor locations. Understanding the cultural, biological, and lifestyle factors that vary between White, African American, and ethnic subgroups of Asian American women may help explain these survival differences.
Appendix
Available only for authorised users
Literature
2.
go back to reference Smith RA, Andrews KS, Brooks D et al (2017) Cancer screening in the United States, 2017: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 67:100–121CrossRefPubMed Smith RA, Andrews KS, Brooks D et al (2017) Cancer screening in the United States, 2017: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 67:100–121CrossRefPubMed
3.
go back to reference DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A (2016) Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin. 66:31–42CrossRefPubMed DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A (2016) Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin. 66:31–42CrossRefPubMed
4.
go back to reference Lohrisch C, Jackson J, Jones A, Mates D, Olivotto IA (2000) Relationship between tumor location and relapse in 6,781 women with early invasive breast cancer. J Clin Oncol 18:2828–2835CrossRefPubMed Lohrisch C, Jackson J, Jones A, Mates D, Olivotto IA (2000) Relationship between tumor location and relapse in 6,781 women with early invasive breast cancer. J Clin Oncol 18:2828–2835CrossRefPubMed
5.
go back to reference Zucali R, Mariani L, Marubini E et al (1998) Early breast cancer: evaluation of the prognostic role of the site of the primary tumor. J Clin Oncol 16:1363–1366CrossRefPubMed Zucali R, Mariani L, Marubini E et al (1998) Early breast cancer: evaluation of the prognostic role of the site of the primary tumor. J Clin Oncol 16:1363–1366CrossRefPubMed
6.
go back to reference Gaffney DK, Tsodikov A, Wiggins CL (2003) Diminished survival in patients with inner versus outer quadrant breast cancers. J Clin Oncol 21:467–472CrossRefPubMed Gaffney DK, Tsodikov A, Wiggins CL (2003) Diminished survival in patients with inner versus outer quadrant breast cancers. J Clin Oncol 21:467–472CrossRefPubMed
7.
go back to reference Siotos C, McColl M, Psoter K et al (2018) Tumor site and breast cancer prognosis. Clinical Breast Cancer 18:e1045–e1052CrossRefPubMed Siotos C, McColl M, Psoter K et al (2018) Tumor site and breast cancer prognosis. Clinical Breast Cancer 18:e1045–e1052CrossRefPubMed
8.
go back to reference Perkins CI, Hotes J, Kohler BA, Howe HL (2004) Association between breast cancer laterality and tumor location, United States, 1994–1998. Cancer Causes Control: CCC 15:637–645CrossRefPubMed Perkins CI, Hotes J, Kohler BA, Howe HL (2004) Association between breast cancer laterality and tumor location, United States, 1994–1998. Cancer Causes Control: CCC 15:637–645CrossRefPubMed
9.
go back to reference Lee AH (2005) Why is carcinoma of the breast more frequent in the upper outer quadrant? A case series based on needle core biopsy diagnoses. Breast (Edinburgh, Scotland) 14:151–152CrossRef Lee AH (2005) Why is carcinoma of the breast more frequent in the upper outer quadrant? A case series based on needle core biopsy diagnoses. Breast (Edinburgh, Scotland) 14:151–152CrossRef
10.
go back to reference Bao J, Yu KD, Jiang YZ, Shao ZM, Di GH (2014) The effect of laterality and primary tumor site on cancer-specific mortality in breast cancer: a SEER population-based study. PLoS ONE 9:e94815CrossRefPubMedPubMedCentral Bao J, Yu KD, Jiang YZ, Shao ZM, Di GH (2014) The effect of laterality and primary tumor site on cancer-specific mortality in breast cancer: a SEER population-based study. PLoS ONE 9:e94815CrossRefPubMedPubMedCentral
11.
go back to reference Colleoni M, Zahrieh D, Gelber RD et al (2005) Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience. J Clin Oncol 23:1390–1400CrossRefPubMed Colleoni M, Zahrieh D, Gelber RD et al (2005) Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience. J Clin Oncol 23:1390–1400CrossRefPubMed
12.
go back to reference Sohn VY, Arthurs ZM, Sebesta JA, Brown TA (2008) Primary tumor location impacts breast cancer survival. Am J Surg 195:641–644CrossRefPubMed Sohn VY, Arthurs ZM, Sebesta JA, Brown TA (2008) Primary tumor location impacts breast cancer survival. Am J Surg 195:641–644CrossRefPubMed
13.
go back to reference Giess CS, Keating DM, Osborne MP, Ng YY, Rosenblatt R (1998) Retroareolar breast carcinoma: clinical, imaging, and histopathologic features. Radiology 207:669–673CrossRefPubMed Giess CS, Keating DM, Osborne MP, Ng YY, Rosenblatt R (1998) Retroareolar breast carcinoma: clinical, imaging, and histopathologic features. Radiology 207:669–673CrossRefPubMed
14.
go back to reference Nicholson BT, Harvey JA, Cohen MA (2009) Nipple-areolar complex: normal anatomy and benign and malignant processes. Radiographics 29:509–523CrossRefPubMed Nicholson BT, Harvey JA, Cohen MA (2009) Nipple-areolar complex: normal anatomy and benign and malignant processes. Radiographics 29:509–523CrossRefPubMed
16.
go back to reference Savaridas SL, Spratt JD, Cox J (2015) Incidence and potential significance of internal mammary lymphadenopathy on computed tomography in patients with a diagnosis of primary breast cancer. Breast Cancer: Basic Clin Res 9:59–65 Savaridas SL, Spratt JD, Cox J (2015) Incidence and potential significance of internal mammary lymphadenopathy on computed tomography in patients with a diagnosis of primary breast cancer. Breast Cancer: Basic Clin Res 9:59–65
17.
go back to reference Gou ZC, Liu XY, Xiao Y, Zhao S, Jiang YZ, Shao ZM (2018) Decreased survival in patients with carcinoma of axillary tail versus upper outer quadrant breast cancers: a SEER population-based study. Cancer Manage Res 10:1133–1141CrossRef Gou ZC, Liu XY, Xiao Y, Zhao S, Jiang YZ, Shao ZM (2018) Decreased survival in patients with carcinoma of axillary tail versus upper outer quadrant breast cancers: a SEER population-based study. Cancer Manage Res 10:1133–1141CrossRef
18.
go back to reference Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA (2015) Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA 313:165–173CrossRefPubMed Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA (2015) Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA 313:165–173CrossRefPubMed
19.
go back to reference National Cancer Institute. Surveillance, Epidemiology, and End Results program. SEER incidence data, 1973-2015. National Cancer Institute. Surveillance, Epidemiology, and End Results program. SEER incidence data, 1973-2015.
20.
go back to reference National Cancer Institute. Surveillance, Epidemiology, and End Results program. Quadrants of the Breast. National Cancer Institute. Surveillance, Epidemiology, and End Results program. Quadrants of the Breast.
21.
go back to reference Park JJ, Humble S, Sommers BD, Colditz GA, Epstein AM, Koh HK (2018) Health Insurance for Asian Americans, Native Hawaiians, and Pacific Islanders Under the Affordable Care Act. JAMA Intern Med 178:1128–1129CrossRefPubMedPubMedCentral Park JJ, Humble S, Sommers BD, Colditz GA, Epstein AM, Koh HK (2018) Health Insurance for Asian Americans, Native Hawaiians, and Pacific Islanders Under the Affordable Care Act. JAMA Intern Med 178:1128–1129CrossRefPubMedPubMedCentral
22.
go back to reference Gomez SL, Von Behren J, McKinley M et al (2017) Breast cancer in Asian Americans in California, 1988–2013: increasing incidence trends and recent data on breast cancer subtypes. Breast Cancer Res Treat 164:139–147CrossRefPubMedPubMedCentral Gomez SL, Von Behren J, McKinley M et al (2017) Breast cancer in Asian Americans in California, 1988–2013: increasing incidence trends and recent data on breast cancer subtypes. Breast Cancer Res Treat 164:139–147CrossRefPubMedPubMedCentral
23.
go back to reference VanderWeele TJ (2009) On the distinction between interaction and effect modification. Epidemiology (Cambridge, Mass.). 20:863–871CrossRef VanderWeele TJ (2009) On the distinction between interaction and effect modification. Epidemiology (Cambridge, Mass.). 20:863–871CrossRef
24.
go back to reference Shahar KH, Buchholz TA, Delpassand E et al (2005) Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma. Cancer 103:1323–1329CrossRefPubMed Shahar KH, Buchholz TA, Delpassand E et al (2005) Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma. Cancer 103:1323–1329CrossRefPubMed
25.
go back to reference Warner ET, Tamimi RM, Hughes ME et al (2015) Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol 33:2254–2261CrossRefPubMedPubMedCentral Warner ET, Tamimi RM, Hughes ME et al (2015) Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol 33:2254–2261CrossRefPubMedPubMedCentral
26.
go back to reference Sakamoto G, Sugano H (1991) Pathology of breast cancer: present and prospect in Japan. Breast Cancer Res Treat 18(Suppl 1):S81–S83CrossRefPubMed Sakamoto G, Sugano H (1991) Pathology of breast cancer: present and prospect in Japan. Breast Cancer Res Treat 18(Suppl 1):S81–S83CrossRefPubMed
27.
go back to reference Stemmermann GN (1991) The pathology of breast cancer in Japanese women compared to other ethnic groups: a review. Breast Cancer Res Treat 18(Suppl 1):S67–S72CrossRefPubMed Stemmermann GN (1991) The pathology of breast cancer in Japanese women compared to other ethnic groups: a review. Breast Cancer Res Treat 18(Suppl 1):S67–S72CrossRefPubMed
28.
go back to reference Shoemaker ML, White MC, Wu M, Weir HK, Romieu I (2018) Differences in breast cancer incidence among young women aged 20-49 years by stage and tumor characteristics, age, race, and ethnicity, 2004-2013. Breast Cancer Res Treat 169:595–606CrossRefPubMedPubMedCentral Shoemaker ML, White MC, Wu M, Weir HK, Romieu I (2018) Differences in breast cancer incidence among young women aged 20-49 years by stage and tumor characteristics, age, race, and ethnicity, 2004-2013. Breast Cancer Res Treat 169:595–606CrossRefPubMedPubMedCentral
29.
go back to reference Lamb EP, Pritchard FE, Nouer SS et al (2018) Understanding disparities in breast cancer care in Memphis. Tennessee Am Surg 84:620–627PubMed Lamb EP, Pritchard FE, Nouer SS et al (2018) Understanding disparities in breast cancer care in Memphis. Tennessee Am Surg 84:620–627PubMed
30.
go back to reference Parkes A, Warneke CL, Clifton K et al (2018) Prognostic factors in patients with metastatic breast cancer with bone-only metastases. Oncologist 23:1282–1288CrossRefPubMedPubMedCentral Parkes A, Warneke CL, Clifton K et al (2018) Prognostic factors in patients with metastatic breast cancer with bone-only metastases. Oncologist 23:1282–1288CrossRefPubMedPubMedCentral
31.
go back to reference DeSantis CE, Siegel RL, Sauer AG et al (2016) Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities. CA Cancer J Clin. 66:290–308CrossRefPubMed DeSantis CE, Siegel RL, Sauer AG et al (2016) Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities. CA Cancer J Clin. 66:290–308CrossRefPubMed
32.
go back to reference Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 109:1721–1728CrossRefPubMed Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 109:1721–1728CrossRefPubMed
33.
go back to reference Akinyemiju T, Moore JX, Altekruse SF (2015) Breast cancer survival in African-American women by hormone receptor subtypes. Breast Cancer Res Treat 153:211–218CrossRefPubMedPubMedCentral Akinyemiju T, Moore JX, Altekruse SF (2015) Breast cancer survival in African-American women by hormone receptor subtypes. Breast Cancer Res Treat 153:211–218CrossRefPubMedPubMedCentral
34.
go back to reference Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA (2006) Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol 24:1342–1349CrossRefPubMed Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA (2006) Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol 24:1342–1349CrossRefPubMed
35.
go back to reference Kwan ML, John EM, Caan BJ et al (2014) Obesity and mortality after breast cancer by race/ethnicity: The California Breast Cancer Survivorship Consortium. Am J Epidemiol 179:95–111CrossRefPubMed Kwan ML, John EM, Caan BJ et al (2014) Obesity and mortality after breast cancer by race/ethnicity: The California Breast Cancer Survivorship Consortium. Am J Epidemiol 179:95–111CrossRefPubMed
36.
go back to reference Nahleh Z, Otoukesh S, Mirshahidi HR et al (2018) Disparities in breast cancer: a multi-institutional comparative analysis focusing on American Hispanics. Cancer Med 7:2710–2717CrossRefPubMedPubMedCentral Nahleh Z, Otoukesh S, Mirshahidi HR et al (2018) Disparities in breast cancer: a multi-institutional comparative analysis focusing on American Hispanics. Cancer Med 7:2710–2717CrossRefPubMedPubMedCentral
37.
go back to reference Liu N, Johnson KJ, Ma CX (2018) Male breast cancer: an updated surveillance, epidemiology, and end results data analysis. Clin Breast Cancer 18:e997–e1002CrossRefPubMed Liu N, Johnson KJ, Ma CX (2018) Male breast cancer: an updated surveillance, epidemiology, and end results data analysis. Clin Breast Cancer 18:e997–e1002CrossRefPubMed
38.
go back to reference Haji-Jama S, Gorey KM, Luginaah IN, Balagurusamy MK, Hamm C (2013) Health insurance mediation of the Mexican American non-Hispanic white disparity on early breast cancer diagnosis. SpringerPlus 2:285CrossRefPubMedPubMedCentral Haji-Jama S, Gorey KM, Luginaah IN, Balagurusamy MK, Hamm C (2013) Health insurance mediation of the Mexican American non-Hispanic white disparity on early breast cancer diagnosis. SpringerPlus 2:285CrossRefPubMedPubMedCentral
39.
go back to reference Wheeler SB, Reeder-Hayes KE, Carey LA (2013) Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research. Oncologist 18:986–993CrossRefPubMedPubMedCentral Wheeler SB, Reeder-Hayes KE, Carey LA (2013) Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research. Oncologist 18:986–993CrossRefPubMedPubMedCentral
40.
go back to reference Stevenson JKR, Cheung MC, Earle CC et al (2018) Chinese and South Asian ethnicity, immigration status, and clinical cancer outcomes in the Ontario Cancer System. Cancer 124:1473–1482CrossRefPubMed Stevenson JKR, Cheung MC, Earle CC et al (2018) Chinese and South Asian ethnicity, immigration status, and clinical cancer outcomes in the Ontario Cancer System. Cancer 124:1473–1482CrossRefPubMed
41.
go back to reference Gomez SL, Glaser SL (2006) Misclassification of race/ethnicity in a population-based cancer registry (United States). Cancer Causes Control: CCC 17:771–781CrossRefPubMed Gomez SL, Glaser SL (2006) Misclassification of race/ethnicity in a population-based cancer registry (United States). Cancer Causes Control: CCC 17:771–781CrossRefPubMed
42.
go back to reference Swallen KC, Glaser SL, Stewart SL, West DW, Jenkins CN, McPhee SJ (1998) Accuracy of racial classification of Vietnamese patients in a population-based cancer registry. Ethn Dis 8:218–227PubMed Swallen KC, Glaser SL, Stewart SL, West DW, Jenkins CN, McPhee SJ (1998) Accuracy of racial classification of Vietnamese patients in a population-based cancer registry. Ethn Dis 8:218–227PubMed
43.
go back to reference Duggan MA, Anderson WF, Altekruse S, Penberthy L, Sherman ME (2016) The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: toward strengthening the critical relationship. Am J Surg Pathol 40:e94–e102CrossRefPubMedPubMedCentral Duggan MA, Anderson WF, Altekruse S, Penberthy L, Sherman ME (2016) The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: toward strengthening the critical relationship. Am J Surg Pathol 40:e94–e102CrossRefPubMedPubMedCentral
44.
Metadata
Title
Do breast quadrants explain racial disparities in breast cancer outcomes?
Authors
Yunan Han
Justin Xavier Moore
Marvin Langston
Lindsay Fuzzell
Saira Khan
Marquita W. Lewis
Graham A. Colditz
Ying Liu
Publication date
01-11-2019
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 11/2019
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-019-01222-x

Other articles of this Issue 11/2019

Cancer Causes & Control 11/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine